The Mississippi State Department of Health reports another case of West Nile virus in the state:
(Jackson, MS) Today, the Mississippi State Department of Health (MSDH) reports one additional human case of West Nile virus (WNV) for 2008. The new case is in Madison County.
The MSDH reports both confirmed and probable cases to the public. The state’s total number of human cases is now two. Last week the agency confirmed the state’s first WNV case in Lincoln County.
MSDH conducts statewide mosquito testing with its most intensive surveillance during peak mosquito reproduction time, which is usually July, August and September.
My biotech company has had encouraging results treating West Nile virus encephalitis since 2003: 81% treatment success rate in people (22 of 27), 75% in horses (6 of 8), and 50% in birds (6 of 12).
Our approach works best when people first have symptoms of a fever and headache. But we’ve been able to help people even a few years after the initial episode of WNV encephalitis.
Our first 8 WNV patients were published in a peer-reviewed medical journal in 2004 (1). We’re eager to see if our approach works again this year.
The drugs we use are already approved by the FDA for blood pressure. They seem to be anti-inflammatory, too. People with a normal immune system who get sick from the West Nile virus appear to overdo their immune response to the virus. Our approach is meant to gently calm down their exaggerated immune response, the so-called “cytokine storm.” It can be used in the very old, the very young, and everybody in between.
It can also be used for almost any virus except the herpes viruses, which is why our approach was included in the BioShield II Act of April 28, 2005, co-sponsored by Senators Lieberman, Hatch, and Brownback. The bill was never debated, but our approach was mentioned in Section 2151 (http://www.govtrack.us/congress/billtext.xpd?bill=s109-975). In 2004, I briefed the White House and the Dept of Homeland Security about it. The UN is aware of our approach in the context of bird flu, although they haven’t tested it, preferring to push Roche’s drug Tamiflu instead.
The drugs we use cost about $1 a tablet. We use one or two pills a day.
Anybody who wants to download our WNV trial protocol can do so for free at any time by clicking on the “West Nile trial” link on our company’s homepage at http://www.genomed.com.
Reference
1: Moskowitz DW, Johnson FE. The central role of angiotensin I-converting enzyme in vertebrate pathophysiology. Curr Top Med Chem. 2004;4(13):1433-54. PMID: 15379656 (For PDF file, click on paper #6 at: http://www.genomed.com/index.cfm?action=investor&drill=publications) — see Table 2 for WNV patients
Sincerely,
Dave Moskowitz MD FACP
CEO, GenoMed, Inc.
http://www.genomed.com
“The public health company™”
Ticker symbol: GMED (on the Pink Sheets)